Titolo della ricerca: Quality of Life: An Increasingly Important Feature of Myeloma TreatmentProgetto di ricerca:Multiple Myeloma (MM) patients have a substantially reduced Health related Quality of Life (HQOL) at diagnosis (dx) due to disease related symptoms like bone pain and fatigue. HQOL monitoring is becoming increasingly important, owing to improved survival and the impact of treatment-related toxicity. As a result, HQOL assessments are increasingly been used in clinical trials, but the literature regarding the relationship between HQOL and outcomes in MM is sparse. GIMEMA has designed the CLARITY study to investigate QOL in MM patients. For the framework of this project, we need a person dedicated to collect data from patients enrolled in the protocol, to insert data into the clinico-scientific database and to check the accuracy of the clinico-hematologic data in accordance with the experimental protocol standards.
BANDO N. 17/2018 DI SELEZIONE PER IL CONFERIMENTO DI ASSEGNI PER LO SVOLGIMENTO DI ATTIVITÀ DI RICERCA DI CATEGORIA B) – SSD MED/15 – TIPO I
Data di aggiornamento: 11/01/2019 - 11:31
Tipologia bando:
Assegni di ricerca
Codice bando:
17/2018
SSD:
Bando:
Data pubblicazione:
Mer, 10/10/2018
Data scadenza:
Ven, 09/11/2018
decreto approvazione atti:
Allegati vari:
SPC:
2018-0070-1725-136139